Fonte: Frontiers in Pharmacology. Unidade: FOB
Assuntos: CAMUNDONGOS, DIABETES MELLITUS, DOENÇAS PERIODONTAIS, RENINA, SISTEMA RENINA-ANGIOTENSINA, INFLAMAÇÃO, CITOCINAS, QUIMIOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Sandra Helena Penha et al. Aliskiren attenuates the inflammatory response and wound healing process in diabetic mice with periodontal disease. Frontiers in Pharmacology, v. 10, 2019Tradução . . Disponível em: https://doi.org/10.3389/fphar.2019.00708. Acesso em: 29 jun. 2024.APA
Oliveira, S. H. P., Brito, V. G. B., Frasnelli, S. C. T., Ribeiro, B. da S., Ferreira, M. N., Queiroz, D. P., et al. (2019). Aliskiren attenuates the inflammatory response and wound healing process in diabetic mice with periodontal disease. Frontiers in Pharmacology, 10. doi:10.3389/fphar.2019.00708NLM
Oliveira SHP, Brito VGB, Frasnelli SCT, Ribeiro B da S, Ferreira MN, Queiroz DP, Beltan CT, Lara VS, Santos CF. Aliskiren attenuates the inflammatory response and wound healing process in diabetic mice with periodontal disease [Internet]. Frontiers in Pharmacology. 2019 ; 10[citado 2024 jun. 29 ] Available from: https://doi.org/10.3389/fphar.2019.00708Vancouver
Oliveira SHP, Brito VGB, Frasnelli SCT, Ribeiro B da S, Ferreira MN, Queiroz DP, Beltan CT, Lara VS, Santos CF. Aliskiren attenuates the inflammatory response and wound healing process in diabetic mice with periodontal disease [Internet]. Frontiers in Pharmacology. 2019 ; 10[citado 2024 jun. 29 ] Available from: https://doi.org/10.3389/fphar.2019.00708
